2019
DOI: 10.1016/j.euf.2019.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Examining Mannitol Use in Kidney Cancer Surgery: A Cautionary Tale of Extrapolated Surgical Data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…In this issue, Nahar et al [10] argue that a reasonable ischemia period is unlikely to damage the kidney and should not be a metric of quality for partial nephrectomy. Meanwhile, Nair et al [11] contextualize findings from a phase 3 clinical trial that assessed the utility of intravenous mannitol administration during NSS.…”
Section: What and How To Cutmentioning
confidence: 99%
“…In this issue, Nahar et al [10] argue that a reasonable ischemia period is unlikely to damage the kidney and should not be a metric of quality for partial nephrectomy. Meanwhile, Nair et al [11] contextualize findings from a phase 3 clinical trial that assessed the utility of intravenous mannitol administration during NSS.…”
Section: What and How To Cutmentioning
confidence: 99%
“…Renal ischemia-reperfusion (I/R) injury (IRI) occurs clinically in different circumstances, such as partial nephrectomy [ 1 ], renal transplantation [ 2 ], complex cardiovascular surgeries requiring cardiac arrest [ 3 , 4 ], postresuscitation shock [ 5 ], and chemical agent/drug-induced renal toxicity [ 6 ]. It is the most familiar cause of the development of acute renal injury and an important influential factor for kidney transplant prognosis [ 2 , 7 ].…”
Section: Introductionmentioning
confidence: 99%